These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14615393)

  • 1. Reduction of atherosclerotic plaques by lysosomal acid lipase supplementation.
    Du H; Schiavi S; Wan N; Levine M; Witte DP; Grabowski GA
    Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):147-54. PubMed ID: 14615393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme therapy for lysosomal acid lipase deficiency in the mouse.
    Du H; Schiavi S; Levine M; Mishra J; Heur M; Grabowski GA
    Hum Mol Genet; 2001 Aug; 10(16):1639-48. PubMed ID: 11487567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy.
    Du H; Levine M; Ganesa C; Witte DP; Cole ES; Grabowski GA
    Am J Hum Genet; 2005 Dec; 77(6):1061-74. PubMed ID: 16380916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions.
    Hakala JK; Oksjoki R; Laine P; Du H; Grabowski GA; Kovanen PT; Pentikäinen MO
    Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1430-6. PubMed ID: 12750117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor alpha.
    Villablanca A; Lubahn D; Shelby L; Lloyd K; Barthold S
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1055-61. PubMed ID: 15117737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomal acid lipase and atherosclerosis.
    Du H; Grabowski GA
    Curr Opin Lipidol; 2004 Oct; 15(5):539-44. PubMed ID: 15361789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death.
    Cozen AE; Moriwaki H; Kremen M; DeYoung MB; Dichek HL; Slezicki KI; Young SG; Véniant M; Dichek DA
    Circulation; 2004 May; 109(17):2129-35. PubMed ID: 15096455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent effects of the catalytic and bridging functions of hepatic lipase on atherosclerosis.
    Dichek HL; Qian K; Agrawal N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1696-702. PubMed ID: 15205216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
    Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
    Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
    Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models.
    Reddy ST; Nguyen JT; Grijalva V; Hough G; Hama S; Navab M; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1676-81. PubMed ID: 15242861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice.
    Whitman SC; Rateri DL; Szilvassy SJ; Yokoyama W; Daugherty A
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1049-54. PubMed ID: 14988092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
    Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic lipase deficiency delays atherosclerosis, myocardial infarction, and cardiac dysfunction and extends lifespan in SR-BI/apolipoprotein E double knockout mice.
    Karackattu SL; Trigatti B; Krieger M
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):548-54. PubMed ID: 16397139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications.
    Chi H; Messas E; Levine RA; Graves DT; Amar S
    Circulation; 2004 Sep; 110(12):1678-85. PubMed ID: 15353494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically determined resistance to collagenase action augments interstitial collagen accumulation in atherosclerotic plaques.
    Fukumoto Y; Deguchi JO; Libby P; Rabkin-Aikawa E; Sakata Y; Chin MT; Hill CC; Lawler PR; Varo N; Schoen FJ; Krane SM; Aikawa M
    Circulation; 2004 Oct; 110(14):1953-9. PubMed ID: 15451791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
    Bursill CA; Choudhury RP; Ali Z; Greaves DR; Channon KM
    Circulation; 2004 Oct; 110(16):2460-6. PubMed ID: 15477414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Jawien J; Csanyi G; Gajda M; Mateuszuk L; Lomnicka M; Korbut R; Chlopicki S
    Eur J Pharmacol; 2007 Feb; 556(1-3):129-35. PubMed ID: 17174298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.